{"article":{"annotation":{"article_id":"singapore-hpv9-vaccine-schedule-january-2027","available_at":"2026-10-07T03:14:16.280829Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"77aa1540d13bd1c5a988c7fd11f52a5e149b2aa3288298d8f38e6cd9b3273dc0","input_sha256":"46c9b68666e16928459190a48f52bc757f44efb9720caf0832bcf2a0e3181ff1","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"SG","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.moh.gov.sg/newsroom/hpv9-vaccine-added-to-national-immunisation-schedules-from-january-2027-/"]}],"geometry":null,"id":"iso3166-1:SG","kind":"country-or-area","labels":{"ar":"سنغافورة","en":"Singapore","es":"Singapur","fr":"Singapour"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null},{"admin1":null,"city":"Singapore","coordinate_note":"UNGEGN city reference point from the cited source; source does not publish a positional uncertainty. Approximate gazetteer point only, not a city boundary, facility, project site, event location, or coverage footprint.","coordinate_reference_system":"OGC:CRS84","coordinate_source":"United Nations Cartographic Section","country":"SG","evidence":[{"field":"en.title+en.summary+en.body+country","language":"en","note":"Explicit article mention: Singapore. Country agrees with the preserved article scope. Gazetteer reference only; event location is unconfirmed.","source_urls":["https://www.moh.gov.sg/newsroom/hpv9-vaccine-added-to-national-immunisation-schedules-from-january-2027-/","https://ungegn.un.org/dashboard/cities/details?id=112","https://ungegn-api.azurewebsites.net/API/GetCitiesDetails/112"]}],"geometry":{"coordinates":[103.862396307,1.28716598445],"type":"Point"},"id":"ungegn-city:112","kind":"city","labels":{"ar":"سنغافورة","en":"Singapore","es":"Singapur","fr":"Singapour"},"match_status":"candidate","precision":"approximate","role":"source-mentioned-place","uncertainty_m":null}],"rules_sha256":"d28c9c89703b56bd91fd887965d416d0115c2473d4bfbd3e558bcceafc3941dd","schema_version":1,"subjects":[{"concept_id":"medtop:20000448","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: HPV9","source_urls":["https://www.moh.gov.sg/newsroom/hpv9-vaccine-added-to-national-immunisation-schedules-from-january-2027-/"]}],"method":"controlled-rules-v1","rule_id":"communicable-disease","status":"candidate"},{"concept_id":"medtop:20000447","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: cancers","source_urls":["https://www.moh.gov.sg/newsroom/hpv9-vaccine-added-to-national-immunisation-schedules-from-january-2027-/"]}],"method":"controlled-rules-v1","rule_id":"cancer","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027?lang=es","category":"health","content":{"key_points":[],"paragraphs":["El Ministerio de Salud de Singapur anunció el 2 de octubre que la vacuna nonavalente HPV9 se añadirá al Calendario Nacional de Inmunización Infantil, al Calendario Nacional de Inmunización de Adultos y a la Lista de Vacunas Subvencionadas desde el 1 de enero de 2027. El cambio abarca a mujeres elegibles que sean ciudadanas singapurenses o residentes permanentes y tengan entre 9 y 26 años; HPV2 seguirá como alternativa. El ministerio indica que los tipos 16 y 18 del VPH se asocian con cerca del 70 % de los cánceres cervicales y que otros tipos cubiertos por HPV9 representan un 20 % adicional, con una cobertura conjunta de tipos de alrededor del 90 %.","El anuncio recomienda dos dosis para mujeres no vacunadas que comienzan entre los 9 y 14 años y tres para quienes empiezan entre los 15 y 26; una pauta incompleta puede terminarse después de los 26 años y hasta los 45. Algunas alumnas de secundaria que iniciaron HPV2 en 2026 recibirán HPV9 como segunda dosis en 2027. La cobertura de tipos no mide la eficacia de la vacuna ni la probabilidad individual de protección; no se recomiendan dosis adicionales de HPV9 a quienes hayan completado la pauta recomendada."],"sections":[]},"corrections":[{"at":"2026-10-07T00:55:21+03:00","language":"es","text":"Se añadieron a este artículo las ediciones alemana y portuguesa y las traducciones de las explicaciones de datos y correcciones."},{"at":"2026-10-07T05:58:40+03:00","language":"es","text":"Se corrigió la clasificación de los datos: los identificadores y tipos de medida siguen ahora las reglas del conjunto de datos. No cambió ninguna cifra, unidad ni fecha."}],"country":"SG","data":{"blocks":[{"description":{"ar":"قواعد البرنامج التي أعلنتها وزارة الصحة في 2 أكتوبر 2026 لتدخل حيز التنفيذ في 1 يناير 2027، إضافة إلى حصص سرطانات عنق الرحم المرتبطة بأنواع HPV التي تغطيها اللقاحات.","de":"Am 2. Oktober 2026 vom Gesundheitsministerium angekündigte Programmregeln für den 1. Januar 2027 sowie Anteile von Gebärmutterhalskrebsfällen, die mit von den Impfstoffen abgedeckten HPV-Typen verbunden sind.","en":"Programme rules announced by the Ministry of Health on 2 October 2026 for 1 January 2027, plus the shares of cervical cancers associated with HPV types covered by the vaccines.","es":"Normas del programa anunciadas por el Ministerio de Salud el 2 de octubre de 2026 para el 1 de enero de 2027, además de las proporciones de cánceres cervicales asociadas a los tipos de VPH cubiertos por las vacunas.","fr":"Règles du programme annoncées par le ministère de la Santé le 2 octobre 2026 pour le 1er janvier 2027, ainsi que les parts de cancers du col associées aux types de HPV couverts par les vaccins.","pt":"Regras do programa anunciadas pelo Ministério da Saúde em 2 de outubro de 2026 para 1º de janeiro de 2027, além das proporções de cânceres do colo do útero associadas a tipos de HPV cobertos pelas vacinas.","tr":"Sağlık Bakanlığının 2 Ekim 2026 duyurusunda açıklanan, 1 Ocak 2027'de yürürlüğe girecek program kuralları ve aşıların kapsadığı kanserle ilişkili HPV türleri."},"id":"hpv9-schedule-and-type-coverage","items":[{"basis":"target","label":{"ar":"الجرعات الموصى بها لمن يبدأن تطعيم HPV في عمر 9–14 عاماً","de":"Empfohlene Dosen bei Beginn der HPV-Impfung im Alter von 9 bis 14 Jahren","en":"Recommended doses for those starting HPV vaccination at ages 9–14","es":"Dosis recomendadas para quienes empiezan la vacunación contra el VPH entre los 9 y 14 años","fr":"Doses recommandées pour un début de vaccination HPV entre 9 et 14 ans","pt":"Doses recomendadas para quem começa a vacinação contra HPV entre 9 e 14 anos","tr":"İlk HPV dozunu 9–14 yaşında alanlar için önerilen doz sayısı"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"singapore","id":"singapore-hpv-vaccine-recommended-doses-start-age-9-14","periodRole":"announcement-date","unitCode":"count"},"period":"2027-01-01","unit":"doses","value":2},{"basis":"target","label":{"ar":"الجرعات الموصى بها لمن يبدأن تطعيم HPV في عمر 15–26 عاماً","de":"Empfohlene Dosen bei Beginn der HPV-Impfung im Alter von 15 bis 26 Jahren","en":"Recommended doses for those starting HPV vaccination at ages 15–26","es":"Dosis recomendadas para quienes empiezan la vacunación contra el VPH entre los 15 y 26 años","fr":"Doses recommandées pour un début de vaccination HPV entre 15 et 26 ans","pt":"Doses recomendadas para quem começa a vacinação contra HPV entre 15 e 26 anos","tr":"İlk HPV dozunu 15–26 yaşında alanlar için önerilen doz sayısı"},"measure":{"aggregation":"stock","frequency":"irregular","geography":"singapore","id":"singapore-hpv-vaccine-recommended-doses-start-age-15-26","periodRole":"announcement-date","unitCode":"count"},"period":"2027-01-01","unit":"doses","value":3}],"methodology":{"ar":"يمثل رقما 70% و20% الإضافية تقديرات المصدر لحصص سرطانات عنق الرحم المرتبطة بأنواع HPV؛ ولا يعبران عن الفعالية السريرية للقاح أو معدل الحماية الفردية. ويصف الإجمالي التقريبي البالغ 90% نطاق الأنواع المذكور في المصدر. وأعداد الجرعات توصيات البرنامج للإناث غير المطعّمات اللواتي يبدأن ضمن الأعمار المحددة؛ أما التطعيم السابق والحالات السريرية الفردية فيتطلبان مشورة طبية.","de":"Die Angaben von 70 Prozent und weiteren 20 Prozent sind Schätzungen der Quelle zu Anteilen von Gebärmutterhalskrebsfällen, die mit HPV-Typen verbunden sind; sie messen weder die klinische Impfstoffwirksamkeit noch den individuellen Schutz. Die ungefähren 90 Prozent beschreiben die von der Quelle genannte Typabdeckung. Dosenzahlen sind Programmempfehlungen für bislang nicht geimpfte Frauen, die im genannten Alter beginnen; frühere Impfungen und individuelle medizinische Umstände erfordern ärztliche Beratung.","en":"The release’s 70% and further 20% figures are source estimates of the shares of cervical cancers associated with HPV types; they are not clinical vaccine efficacy or individual protection rates. The approximately 90% total describes the type coverage stated by the source. Dose counts are programme recommendations for unvaccinated females starting at the stated ages; prior vaccination and individual clinical circumstances require medical advice.","es":"Las cifras del 70 % y del 20 % adicional son estimaciones de la fuente sobre las proporciones de cánceres cervicales asociadas a tipos de VPH; no son medidas de eficacia clínica de la vacuna ni de protección individual. El total aproximado del 90 % describe la cobertura de tipos indicada por la fuente. El número de dosis corresponde a recomendaciones del programa para mujeres no vacunadas que empiezan a las edades señaladas; la vacunación previa y las circunstancias clínicas individuales requieren consejo médico.","fr":"Les valeurs de 70 % et de 20 % supplémentaires sont les estimations de la source concernant les parts de cancers du col associées aux types de HPV ; elles ne mesurent ni l’efficacité clinique du vaccin ni la protection individuelle. Le total d’environ 90 % décrit la couverture des types indiquée par la source. Les nombres de doses sont les recommandations du programme pour les femmes non vaccinées qui commencent aux âges précisés ; les antécédents vaccinaux et la situation clinique individuelle nécessitent un avis médical.","pt":"Os valores de 70% e mais 20% do comunicado são estimativas da fonte sobre a proporção de cânceres do colo do útero associados a tipos de HPV; não medem a eficácia clínica da vacina nem a proteção individual. O total aproximado de 90% descreve a cobertura de tipos indicada pela fonte. A quantidade de doses são recomendações do programa para mulheres não vacinadas que iniciam nas idades indicadas; vacinação prévia e circunstâncias clínicas individuais requerem orientação médica.","tr":"Duyurudaki %70 ve ek %20, rahim ağzı kanserlerinin HPV türleriyle ilişkilendirilen paylarına ilişkin kaynak tahminleridir; klinik aşı etkinliği veya bireysel korunma oranı değildir. Yaklaşık %90 toplamı bu payların kaynakta belirtilen kapsamıdır. Doz sayıları, ilk dozu belirtilen yaşta alan aşılanmamış kadınlara yönelik hedef önerilerdir; önceki aşı durumu ve kişisel klinik durum için doktor önerisi gerekir."},"sourceUrls":["https://www.moh.gov.sg/newsroom/hpv9-vaccine-added-to-national-immunisation-schedules-from-january-2027-/"],"title":{"ar":"جدول HPV9 في سنغافورة ونطاق أنواع فيروس HPV","de":"Impfplan und HPV-Typabdeckung in Singapur","en":"Singapore’s HPV9 schedule and HPV-type coverage","es":"Calendario HPV9 de Singapur y cobertura de tipos de VPH","fr":"Programme HPV9 de Singapour et couverture des types de HPV","pt":"Calendário da HPV9 e cobertura de tipos de HPV em Singapura","tr":"Singapur'un HPV9 programı ve HPV türü kapsamı"},"type":"metrics","updatedAt":"2026-10-07T00:55:21+03:00"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027/data/hpv9-schedule-and-type-coverage?lang=es&format=csv","json":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027/data/hpv9-schedule-and-type-coverage?lang=es&format=json"},"id":"hpv9-schedule-and-type-coverage"}],"data_types":["metrics"],"editorial_illustration":{"alt":"Ilustración conceptual de salud pública, investigación y datos conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-20c64f38-1920-566b-9254-1b0e2a57f948","event_period":"2026-10-02","event_period_basis":"event-or-reference-period","id":"singapore-hpv9-vaccine-schedule-january-2027","image":null,"importance":0.6,"language":"es","modified_at":"2026-10-07T05:58:40+03:00","publication_basis":"publication-record","published_at":"2026-10-04T14:04:24+00:00","reading_minutes":2,"region":"world","section_illustration":{"alt":"Ilustración conceptual de salud pública, investigación y datos conectados.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"es","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"singapore-hpv9-vaccine-schedule-january-2027","sources":[{"checkedAt":"2026-10-04","name":"Ministry of Health, Singapore","publishedAt":"2026-10-02","url":"https://www.moh.gov.sg/newsroom/hpv9-vaccine-added-to-national-immunisation-schedules-from-january-2027-/"}],"summary":"HPV9 se incorporará a los calendarios de inmunización infantil y adulta de Singapur para mujeres elegibles desde el 1 de enero de 2027. El ministerio afirma que los tipos de VPH cubiertos se asocian con cerca del 90 % de los cánceres cervicales.","text":"HPV9 se incorporará a los calendarios de inmunización infantil y adulta de Singapur para mujeres elegibles desde el 1 de enero de 2027. El ministerio afirma que los tipos de VPH cubiertos se asocian con cerca del 90 % de los cánceres cervicales.\n\nEl Ministerio de Salud de Singapur anunció el 2 de octubre que la vacuna nonavalente HPV9 se añadirá al Calendario Nacional de Inmunización Infantil, al Calendario Nacional de Inmunización de Adultos y a la Lista de Vacunas Subvencionadas desde el 1 de enero de 2027. El cambio abarca a mujeres elegibles que sean ciudadanas singapurenses o residentes permanentes y tengan entre 9 y 26 años; HPV2 seguirá como alternativa. El ministerio indica que los tipos 16 y 18 del VPH se asocian con cerca del 70 % de los cánceres cervicales y que otros tipos cubiertos por HPV9 representan un 20 % adicional, con una cobertura conjunta de tipos de alrededor del 90 %.\n\nEl anuncio recomienda dos dosis para mujeres no vacunadas que comienzan entre los 9 y 14 años y tres para quienes empiezan entre los 15 y 26; una pauta incompleta puede terminarse después de los 26 años y hasta los 45. Algunas alumnas de secundaria que iniciaron HPV2 en 2026 recibirán HPV9 como segunda dosis en 2027. La cobertura de tipos no mide la eficacia de la vacuna ni la probabilidad individual de protección; no se recomiendan dosis adicionales de HPV9 a quienes hayan completado la pauta recomendada.\n\nSe añadieron a este artículo las ediciones alemana y portuguesa y las traducciones de las explicaciones de datos y correcciones.\n\nSe corrigió la clasificación de los datos: los identificadores y tipos de medida siguen ahora las reglas del conjunto de datos. No cambió ninguna cifra, unidad ni fecha.","title":"Singapur incorporará la vacuna HPV9 a los calendarios nacionales en 2027","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/singapore-hpv9-vaccine-schedule-january-2027"},{"api_url":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027?lang=en","language":"en","url":"https://newsverum.com/en/news/singapore-hpv9-vaccine-schedule-january-2027"},{"api_url":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/singapore-hpv9-vaccine-schedule-january-2027"},{"api_url":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/singapore-hpv9-vaccine-schedule-january-2027"},{"api_url":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027?lang=es","language":"es","url":"https://newsverum.com/es/news/singapore-hpv9-vaccine-schedule-january-2027"},{"api_url":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027?lang=de","language":"de","url":"https://newsverum.com/de/news/singapore-hpv9-vaccine-schedule-january-2027"},{"api_url":"https://newsverum.com/api/v1/articles/singapore-hpv9-vaccine-schedule-january-2027?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/singapore-hpv9-vaccine-schedule-january-2027"}],"url":"https://newsverum.com/es/news/singapore-hpv9-vaccine-schedule-january-2027"},"version":"1"}